HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

FCE 26644

inhibits binding of basic fibroblast growth factor, platelet-derived growth factor beta and IL-7 to their receptors; structure in first source
Also Known As:
7,7'-(carbonyl-bis(imino-N-methyl-4,2-pyrrolcarbonylimino(N-methyl-4,2-pyrrol)carbonylimino))-bis(1,3-naphthalenedisulfonic acid); FCE-26644; PNU 145156E
Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Related Diseases

1. Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
2. Neoplasms (Cancer)
3. Melanoma (Melanoma, Malignant)
4. Non-Hodgkin Lymphoma (Lymphosarcoma)
5. Fibrosarcoma

Related Drugs and Biologics

1. Insulin-Like Growth Factor I (IGF-1)
2. FCE 27784
3. stallimycin
4. Suramin (Suramin Sodium)
5. Cyclophosphamide (Cytoxan)